Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Not yet recruiting 2Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Conditions

Papillomavirus Infections 1Intestinal Neoplasms 1CIN 2/3 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Artesunate × Clear all
NCT07095309 2025-07-31

NeoART-M

Metanoic Health Ltd.

Phase 2 Not yet recruiting
120 enrolled

Intestinal Neoplasms

NCT07095478 2025-07-31

NeoART-CIN

Metanoic Health Ltd.

Phase 2 Not yet recruiting
28 enrolled

CIN 2/3

NCT05555862 2025-05-18

anal HSIL HIV-

Frantz Viral Therapeutics, LLC

Phase 2 Active not recruiting
17 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡